» Articles » PMID: 25343021

Strategies for Osteochondral Repair: Focus on Scaffolds

Overview
Journal J Tissue Eng
Date 2014 Oct 25
PMID 25343021
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Interest in osteochondral repair has been increasing with the growing number of sports-related injuries, accident traumas, and congenital diseases and disorders. Although therapeutic interventions are entering an advanced stage, current surgical procedures are still in their infancy. Unlike other tissues, the osteochondral zone shows a high level of gradient and interfacial tissue organization between bone and cartilage, and thus has unique characteristics related to the ability to resist mechanical compression and restoration. Among the possible therapies, tissue engineering of osteochondral tissues has shown considerable promise where multiple approaches of utilizing cells, scaffolds, and signaling molecules have been pursued. This review focuses particularly on the importance of scaffold design and its role in the success of osteochondral tissue engineering. Biphasic and gradient composition with proper pore configurations are the basic design consideration for scaffolds. Surface modification is an essential technique to improve the scaffold function associated with cell regulation or delivery of signaling molecules. The use of functional scaffolds with a controllable delivery strategy of multiple signaling molecules is also considered a promising therapeutic approach. In this review, we updated the recent advances in scaffolding approaches for osteochondral tissue engineering.

Citing Articles

Modern Approach to Testing the Biocompatibility of Osteochondral Scaffolds in Accordance with the 3Rs Principle─Preclinical , , and Studies Using the Biphasic Curdlan-Based Biomaterial.

Klimek K, Terpilowska S, Michalak A, Bernacki R, Nurzynska A, Cucchiarini M ACS Biomater Sci Eng. 2025; 11(2):845-865.

PMID: 39832791 PMC: 11815629. DOI: 10.1021/acsbiomaterials.4c01107.


A phosphate glass reinforced composite acrylamide gradient scaffold for osteochondral interface regeneration.

Younus Z, Ahmed I, Roach P, Forsyth N Biomater Biosyst. 2024; 15:100099.

PMID: 39221155 PMC: 11364006. DOI: 10.1016/j.bbiosy.2024.100099.


Polymer-Based Wound Dressings Loaded with Essential Oil for the Treatment of Wounds: A Review.

Buriti B, Figueiredo P, Passos M, da Silva J Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065747 PMC: 11279661. DOI: 10.3390/ph17070897.


Bioinspired gradient scaffolds for osteochondral tissue engineering.

Peng Y, Zhuang Y, Liu Y, Le H, Li D, Zhang M Exploration (Beijing). 2023; 3(4):20210043.

PMID: 37933242 PMC: 10624381. DOI: 10.1002/EXP.20210043.


Kartogenin delivery systems for biomedical therapeutics and regenerative medicine.

Chen P, Liao X Drug Deliv. 2023; 30(1):2254519.

PMID: 37665332 PMC: 10478613. DOI: 10.1080/10717544.2023.2254519.


References
1.
Niemeyer P, Pestka J, Kreuz P, Erggelet C, Schmal H, Suedkamp N . Characteristic complications after autologous chondrocyte implantation for cartilage defects of the knee joint. Am J Sports Med. 2008; 36(11):2091-9. DOI: 10.1177/0363546508322131. View

2.
Diederichs S, Baral K, Tanner M, Richter W . Interplay between local versus soluble transforming growth factor-beta and fibrin scaffolds: role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng Part A. 2012; 18(11-12):1140-50. DOI: 10.1089/ten.TEA.2011.0426. View

3.
Reverte-Vinaixa M, Joshi N, Diaz-Ferreiro E, Teixidor-Serra J, Dominguez-Oronoz R . Medium-term outcome of mosaicplasty for grade III-IV cartilage defects of the knee. J Orthop Surg (Hong Kong). 2013; 21(1):4-9. DOI: 10.1177/230949901302100104. View

4.
Grande D, Breitbart A, Mason J, Paulino C, Laser J, Schwartz R . Cartilage tissue engineering: current limitations and solutions. Clin Orthop Relat Res. 1999; (367 Suppl):S176-85. DOI: 10.1097/00003086-199910001-00019. View

5.
Maehara H, Sotome S, Yoshii T, Torigoe I, Kawasaki Y, Sugata Y . Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor-2 (FGF-2). J Orthop Res. 2009; 28(5):677-86. DOI: 10.1002/jor.21032. View